Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases
European Journal of Immunology · 2025
DOI: 10.1002/eji.202249978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Marc Ehlers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratories of Immunology and Antibody Glycan Analysis, Institute of Nutritional Medicine, University of Lübeck and University Medical Center of Sch…. Hauptthemen laut MEDLINE: Hypersensitivity, Immunoglobulin E, Immunoglobulin G, Antibody Formation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Volkswagen Foundation, Agence National de la Recherche, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, 398859914 (EH 221/10-1) and 390884018 (Germany's Excellence Strategies- EXC 2167, Precision M….
Abstract (Originalsprache)
Allergen‐specific antibodies, particularly of the IgE class, are a hallmark of many allergic diseases. Yet paradoxically, (1) a proportion of healthy individuals possess allergen‐specific IgE without clinical signs of allergy; (2) some, but not all, allergic individuals develop a more severe disease over time or fail to respond to allergen‐specific immunotherapy; and (3) allergen‐specific IgG antibodies can inhibit IgE‐mediated responses but they can also induce allergic reactions. In this review, we discuss the occurrence of and transition between nonpathogenic and pathogenic allergen‐specific antibody responses in the light of a two‐stage model. We recapitulate different factors and scenarios that may induce different inflammatory conditions and qualitatively distinct allergen‐specific T‐ and B‐cell responses, influencing IgE origins and affinities, IgE/IgG(4) ratios, IgG effector functions, antibody glycosylation patterns, Fc and glycan‐binding receptor expression and involvement, and ultimately their propensity to elicit allergic responses. Differences in these antibody characteristics may determine the onset of symptomatic allergy and the severity or remission of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratories of Immunology and Antibody Glycan Analysis, Institute of Nutritional Medicine, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany.
- Airway Research Center North, German Center for Lung Research (DZL), University of Lübeck, Lübeck, Germany.
- Institut Pasteur, Université de Paris Cité, Unit of Antibodies in Therapy and Pathology, Paris, France.
- CNRS, Paris, France.
ORCID-Profile: Marc Ehlers
Förderung
- Volkswagen Foundation
- Agence National de la Recherche
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, 398859914 (EH 221/10-1) and 390884018 (Germany's Excellence Strategies- EXC 2167, Precision M…
- Deutsches Zentrum für Lungenforschung (DZL, German Center for Lung Research, 82DZLT81C6, to ME)
Zitieren
APA
Ehlers, M., & Jönsson, F. (2025). Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases. European Journal of Immunology. https://doi.org/10.1002/eji.202249978
Vancouver
Ehlers M, Jönsson F. Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases. European Journal of Immunology. 2025. doi:10.1002/eji.202249978
BibTeX
@article{Ehlers2025,
author = {Ehlers, Marc and Jönsson, Friederike},
title = {Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202249978}
}
EUVIMED